The Shotlee Journal
Browse Shotlee articles about Metabolic Health.
Showing 9 / 744 Metabolic Health articles
Stopping Ozempic can lead to full weight regain in about 1.7 years, plus reversal of cardiovascular and metabolic benefits, warns a major BMJ review. Nearly 50% of users discontinue within a year due to side effects and high costs. Doctors urge consulting before quitting to protect your health gains.
South African DJ Shimza set the record straight on Podcast and Chill, firmly denying rumors that his impressive weight loss came from Ozempic or that he profits from government tenders. With his partner Athi Geleba in a high-profile Presidency position, speculation ran wild—but Shimza insists he earns his money through hard work. This candid interview sheds light on celebrity health rumors and tender controversies.
Side-by-side photos of Vanessa Williams highlight her 'Ozempic face' transformation, marked by wrinkles and an 'Ozempic neck' after using Mounjaro for menopause-related weight gain. The first Black Miss America calls it a 'game-changer' at age 60. A plastic surgeon details how GLP-1 drugs affect facial fat and skin health.
Structure Therapeutics announced impressive Phase 2 results for its daily obesity pill, with patients losing about 16% of their body weight compared to placebo after 44 weeks. This positions the company to challenge leaders like Eli Lilly and Novo Nordisk in the race for effective oral GLP-1 therapies. Discover the details and implications for obesity treatment.
This awards season, Hollywood red carpets showcase pin-thin silhouettes from Emma Stone to Jenna Ortega, fueled by Ozempic microdosing. Stylists fear stars are unaware of their extreme thinness, while nutritionists spot muscle wasting and malnutrition signs. As body positivity fades, insiders reveal the pressure and health toll.
For decades, GLP-1 receptor agonists like Ozempic have transformed diabetes and obesity treatment via injections, but patients crave oral options. This guide traces the scientific quest for oral GLP-1s, from early discoveries and Gila monster breakthroughs to Rybelsus challenges and promising algae-based innovations. Understand the barriers and what's next for affordable, pill-based metabolic health.
Zydus Lifesciences and Lupin are teaming up to bring Semaglutide injection to India, positioning it as a rival to Ozempic for type 2 diabetes and chronic weight management. Marketed by Zydus with a user-friendly reusable pen, this GLP-1 therapy offers new options for adults with poor glycemic control or obesity-related conditions. Here's what patients need to know about this launch.
Layla Taylor, star of The Secret Lives of Mormon Wives, has stepped away from GLP-1 medications after using them as an unhealthy crutch for her lifelong eating disorder. Ahead of season 4, she opens up about hidden side effects like aching joints, falling hair, and constant fatigue that signaled her body was breaking down. Her story underscores the importance of monitoring GLP-1 use, especially with pre-existing conditions.
Two women were rushed to the hospital and intubated after receiving peptide injections at a Las Vegas anti-aging festival. Nevada regulators fined providers $35,000 for unlicensed practice and wholesaling. This incident highlights the dangers of unregulated peptides promoted for anti-aging.
